Telix Pharmaceuticals Limited Equity
Telix Pharmaceuticals Limited (TLPPF) had Equity of $415.38 million as of 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Notes
ifrs-full:Equity · last filed 2026-02-20
- 2024-12-31: Equity 568.21M AUD.
- 2023-12-31: Equity 148.91M AUD.
- 2022-12-31: Equity 80.01M AUD.
- 2021-12-31: Equity 2.16M AUD.
AUD
| Period end | Equity |
|---|---|
| 2024-12-31 | 568.21M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 148.91M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 80.01M AUD 20-F · filed 2025-02-24 |
| 2021-12-31 | 2.16M AUD 20-F · filed 2025-02-24 |
USD
| Period end | Equity |
|---|---|
| 2025-12-31 | $415.38M 20-F · filed 2026-02-20 |
| 2024-12-31 | $352.94M 20-F · filed 2026-02-20 |
| 2023-12-31 | $102.64M 20-F · filed 2026-02-20 |
| 2022-12-31 | $54.79M 20-F · filed 2026-02-20 |